Literature DB >> 17044780

Construction and purification of a covalently linked divalent tandem single-chain Fv antibody against placental alkaline phosphatase.

Ali Sheikholvaezin1, David Eriksson, Katrine Riklund, Torgny Stigbrand.   

Abstract

Multivalency is a recognized means to increase the functional affinity of single-chain antibody fragments (scFvs) for optimizing tumor uptake at radioimmunotargeting. A unique divalent tandem single-chain Fv antibody [sc(Fv)2], based on the variable regions of the monoclonal antibody (MAb) H7, has now been generated. The antibody differs from other dimeric single-chain constructs in that a linker sequence (L) is introduced between the repeats of VL and VH domains (VL-L-VH-L-VL-L-VH). This construct was expressed as a His-tagged TrxA fusion protein in the Escherichia coli strain Origami B. Following cleavage with AcTev protease, the antibody was obtained in soluble and active form in E. coli and could be purified by Ni-NTA and cation-exchange chromatography. Purity and immunochemical properties were determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), enzyme-linked immunosorbent assay (ELISA), Western blot, and Biacore analyses. The [sc(Fv)2] displayed proper stability and could be purified to homogeneity. This antibody also maintained immunoreactivity at 42 degrees C with only slight decrease at 52 degrees C. The high affinity displayed by the original antibody H7, 6.7 x 10(9) M(-1), was only slightly decreased to 1.2 x 10(9) M(-1) as determined by Biacore. The generation of such a divalent single-chain Fv with a molecular weight around 60 kd would be of value for clinical applications such as radioimmunolocalization and radioimmunotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044780     DOI: 10.1089/hyb.2006.25.255

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  1 in total

1.  Rationalization and design of the complementarity determining region sequences in an antibody-antigen recognition interface.

Authors:  Chung-Ming Yu; Hung-Pin Peng; Ing-Chien Chen; Yu-Ching Lee; Jun-Bo Chen; Keng-Chang Tsai; Ching-Tai Chen; Jeng-Yih Chang; Ei-Wen Yang; Po-Chiang Hsu; Jhih-Wei Jian; Hung-Ju Hsu; Hung-Ju Chang; Wen-Lian Hsu; Kai-Fa Huang; Alex Che Ma; An-Suei Yang
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.